Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elias Poulakidas
Effectiveness of 5-Azacytidine in Older Patients With High-Risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia: A Retrospective Analysis of the Hellenic (Greek) MDS Study Group
Journal of Geriatric Oncology
Gerontology
Geriatrics
Oncology
Related publications
CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Leukemia Research
Cancer Research
Oncology
Hematology
The Prognostic Significance of Chromosome 17 Abnormalities in Patients With Myelodysplastic Syndrome Treated With 5‐azacytidine: Results From the Hellenic 5‐azacytidine Registry
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
Cancer
Cancer Research
Oncology
Expanded Safety Analysis of Pevonedistat, a First-In-Class NEDD8-activating Enzyme Inhibitor, in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Blood Cancer Journal
Oncology
Hematology
FLAMSA-RIC for Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine
